ZTS
Zoetis Inc.
Zoetis Inc. insider trading
Zoetis Inc. files with the SEC as a Pharmaceutical Preparations company headquartered in Parsippany, NJ. Every time one of its executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.
From SEC filings
Recent ZTS insider transactions
3 insiders traded ZTS on the open market between May 11, 2026 and May 13, 2026 — 3 purchases worth $886.4K.
- Bought
- $886.4K
- Sold
- —
- Net
- +$886.4K
- Insiders
- 3
Damelio Frank A
Director
+$501.3K
May 13, 2026
6,650 sh · $75.39
Bisaro Paul
Director
+$151.8K
May 13, 2026
2,000 sh · $75.88
McCallister Michael B
Director
+$233.3K
May 11, 2026
3,000 sh · $77.76
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| May 13, 2026 | Damelio Frank ADirector | 6,650 | $75.39 | +$501.3K |
| May 13, 2026 | Bisaro PaulDirector | 2,000 | $75.88 | +$151.8K |
| May 11, 2026 | McCallister Michael BDirector | 3,000 | $77.76 | +$233.3K |
SEC Form 4 data, Q3 2024 to Q2 2026
ZTS insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 7 insiders traded ZTS on the open market: 3 purchases worth $886.4K and 8 sales worth $3.6M, 6 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 3 purchases ($886.4K) and 2 sales ($2.5M), by 4 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | +$886.4K3 buys | — | |
| Q1 2026 | — | −$2.5M2 sales · all on a plan | |
| Q4 2025 | — | — | |
| Q3 2025 | — | — | |
| Q2 2025 | — | −$110.8K1 sale · all on a plan | |
| Q1 2025 | — | −$372.1K4 sales · 3 on a plan | |
| Q4 2024 | — | −$617K1 sale | |
| Q3 2024 | — | — |
- Largest purchase
- +$501.3K of ZTS by Damelio Frank A (Director) on May 13, 2026.
- Largest sale
- −$1.4M of ZTS by Peck Kristin C (Chief Executive Officer · Director) on Feb 17, 2026, under a 10b5-1 plan.
Open-market transactions through Jun 30, 2026most recent first
Bisaro Paul
Director
+$151.8K
May 13, 2026
2,000 sh · $75.88
McCallister Michael B
Director
+$233.3K
May 11, 2026
3,000 sh · $77.76
Peck Kristin C10b5-1
Chief Executive Officer · Director
−$1.4M
Feb 17, 2026
10,800 sh · $127.55
Peck Kristin C10b5-1
Chief Executive Officer · Director
−$1.2M
Feb 17, 2026
9,200 sh · $126.46
Lagano Roxanne10b5-1
Executive Vice President
−$110.8K
Jun 03, 2025
652 sh · $170.00
Reed Willie M
Director
−$201K
Mar 11, 2025
1,210 sh · $166.14
Lagano Roxanne10b5-1
Executive Vice President
−$55.4K
Mar 10, 2025
326 sh · $170.00
Peck Kristin C10b5-1
Chief Executive Officer · Director
−$59.9K
Feb 19, 2025
382 sh · $156.68
Lagano Roxanne10b5-1
Executive Vice President
−$55.8K
Feb 11, 2025
326 sh · $171.18
Polzer Robert J
Executive Vice President
−$617K
Nov 25, 2024
3,477 sh · $177.46
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| May 13, 2026 | Bisaro PaulDirector | 2,000 | $75.88 | +$151.8K |
| May 11, 2026 | McCallister Michael BDirector | 3,000 | $77.76 | +$233.3K |
| Feb 17, 2026 | Peck Kristin C10b5-1Chief Executive Officer · Director | 10,800 | $127.55 | −$1.4M |
| Feb 17, 2026 | Peck Kristin C10b5-1Chief Executive Officer · Director | 9,200 | $126.46 | −$1.2M |
| Jun 03, 2025 | Lagano Roxanne10b5-1Executive Vice President | 652 | $170.00 | −$110.8K |
| Mar 11, 2025 | Reed Willie MDirector | 1,210 | $166.14 | −$201K |
| Mar 10, 2025 | Lagano Roxanne10b5-1Executive Vice President | 326 | $170.00 | −$55.4K |
| Feb 19, 2025 | Peck Kristin C10b5-1Chief Executive Officer · Director | 382 | $156.68 | −$59.9K |
| Feb 11, 2025 | Lagano Roxanne10b5-1Executive Vice President | 326 | $171.18 | −$55.8K |
| Nov 25, 2024 | Polzer Robert JExecutive Vice President | 3,477 | $177.46 | −$617K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Zoetis Inc. company record
- SEC industry classification
- Pharmaceutical Preparations
- Headquarters
- Parsippany, NJ
- Listed on
- NYSE
- SEC Central Index Key
- 0001555280
Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.
After insiders bought ZTS
What the stock actually did in the 90 days following each open-market purchase
Don't check ZTS — let it ping you
Get told the moment an insider moves on ZTS
Pro watches Zoetis Inc. for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add ZTS to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.
The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.
How to read ZTS insider activity
- Open-market purchase (code P)
- An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
- Grants and option exercises (codes A, M)
- Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
- Cluster buy
- Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.
Other Health Care tickers
Questions
- Are ZTS insiders buying or selling?
- Between May 11, 2026 and May 13, 2026, 3 Zoetis Inc. insiders made 3 open-market purchases worth $886.4K and no sales, a net purchase of $886.4K.
- How much ZTS stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 7 Zoetis Inc. insiders made 3 open-market purchases worth $886.4K and 8 sales worth $3.6M. 6 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: 3 purchases ($886.4K) and 2 sales ($2.5M). The largest purchase was Damelio Frank A buying $501.3K on May 13, 2026. The largest sale was Peck Kristin C selling $1.4M on Feb 17, 2026.
- What was the largest recent ZTS insider trade?
- Damelio Frank A (Director) bought $501.3K of ZTS stock on May 13, 2026 at about $75.39 a share.
- When did an insider last buy ZTS shares?
- The most recent open-market purchase on file is Damelio Frank A (Director) buying $501.3K on May 13, 2026.
- Where does ZTS insider trading data come from?
- From the Form 4 filings Zoetis Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.